At Genezen, we bring therapies to life. We are a CDMO dedicated to advancing gene and cell therapies by providing science-driven development and manufacturing solutions.

Why Genezen

Our team offers the expertise, technology, and capacity to help bring viral vector-based therapies to patients worldwide.

What Sets Genezen Apart

Deep-seated lentiviral, retroviral, and AAV vector expertise

State-of-the-art viral vector manufacturing facility

Flexible, client-centric programs for a tailored, accelerated experience

Portable viral vector production platforms

The Full Spectrum of Viral Vector Development and Manufacturing Services

Working side by side to build long-term, trust-based partnerships with our clients, we provide flexible and comprehensive product development and manufacturing solutions to meet your program’s unique needs. Genezen offers next-generation bioreactor-based capabilities in lentiviral vector services, is one of the only CDMOs with significant retroviral vector production expertise, and also provides serotype agnostic, scalable solutions and analytical expertise for the manufacture of adeno-associated viral (AAV) vectors.

Explore Genezen

Facilities

Our viral vector facility has the capacity and technologies to accelerate your gene or cell therapy to success.

Read more
Quality

We focus on quality to advance your product through clinical milestones as quickly as possible.

Read more
Project Management

Our team is your team; dedicated partnership and flexible support that molds to your needs.

Read more

Meet Our People

Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can’t wait to talk to you about your current challenges and needs.

Steve Favaloro, CEO of Genezen, a viral vector CDMO for cell and gene therapy.

Steve Favaloro

Chairman and Chief Executive Officer
Susan D’Costa, Chief Technical Officer at Genezen, expert in viral vector manufacturing.

Susan D’Costa, PhD

Chief Technical & Commercial Officer
Steve Favaloro, CEO of Genezen, a viral vector CDMO for cell and gene therapy.

Steve Favaloro

Chairman and Chief Executive Officer
Susan D’Costa, Chief Technical Officer at Genezen, expert in viral vector manufacturing.

Susan D’Costa, PhD

Chief Technical & Commercial Officer